scispace - formally typeset
S

Sha Wang

Researcher at Uppsala University

Publications -  6
Citations -  976

Sha Wang is an academic researcher from Uppsala University. The author has contributed to research in topics: Biology & Medicine. The author has an hindex of 1, co-authored 1 publications receiving 880 citations.

Papers
More filters
Journal ArticleDOI

Circular chromosome conformation capture (4C) uncovers extensive networks of epigenetically regulated intra-and interchromosomal interactions

TL;DR: It is found that the direct interaction between differentially methylated regions was linked to epigenetic regulation of transcription in trans and the patterns of interactions specific to the maternal H19 imprinting control region underwent reprogramming during in vitro maturation of embryonic stem cells.
Journal ArticleDOI

Loading of ”cocktail siRNAs” into extracellular vesicles via TAT-DRBD peptide for the treatment of castration-resistant prostate cancer

TL;DR: Results indicate that delivery of siRNA mixtures by engineered EVs can effectively downregulate AR expression and induce LNCaP-AI cell apoptosis and the potential of TAT as efficient siRNA carriers by keeping the function of the cargoes.
Journal ArticleDOI

Circular RNAs Involve in Immunity of Digestive Cancers From Bench to Bedside: A Review

TL;DR: A new idea for the diagnosis and treatment of gastrointestinal tumors is provided and the relationship between circRNAs and digestive tumor immunity is systematically discussed for the first time.
Journal ArticleDOI

A transposon‐introduced G‐quadruplex motif is selectively retained and constrained to downregulate CYP321A1

TL;DR: It is shown that CYP321A1, a xenobiotic-metabolizing P450 from Helicoverpa zea, a polyphagous insect of economic importance, has acquired and preserved a G4 DNA motif by selectively retaining a transposon known as HzIS1-3 that carries this G4DNA motif in its promoter region.
Journal ArticleDOI

Anchoring super-enhancer-driven oncogenic lncRNAs for anti-tumor therapy in hepatocellular carcinoma.

TL;DR: In this paper , a comprehensive survey of SE-associated lncRNAs in HCC is comprehensively outlined for the first time, which sheds lights on the merit of anchoring SE-driven oncogenic lncRNA for HCC treatment, and siHSAL3 loaded nanoparticles exert anti-tumor effect on HCC in vitro and in vivo.